• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.

作者信息

Hofmann Stefan G

出版信息

Depress Anxiety. 2014 Mar;31(3):175-7. doi: 10.1002/da.22257.

DOI:10.1002/da.22257
PMID:24677604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4006201/
Abstract
摘要

相似文献

1
D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.D-环丝氨酸治疗焦虑症:使良好暴露效果更佳,使不良暴露效果更差。
Depress Anxiety. 2014 Mar;31(3):175-7. doi: 10.1002/da.22257.
2
Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.从D-环丝氨酸中吸取的教训:药物辅助暴露疗法的前景与局限
J Clin Psychiatry. 2013 Apr;74(4):415-6. doi: 10.4088/JCP.13ac08464.
3
D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels.利用聚合物凝胶开发用于焦虑症的D-环丝氨酸鼻腔制剂。
Drug Discov Ther. 2018;12(3):142-153. doi: 10.5582/ddt.2018.01017.
4
Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?学会遗忘:暴露后给予 D-环丝氨酸是否能增强广场恐怖症的恐惧消退?
J Psychiatr Res. 2018 Oct;105:153-163. doi: 10.1016/j.jpsychires.2018.08.016. Epub 2018 Aug 11.
5
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.D-环丝氨酸给药剂量和时间的变化解释了其增强焦虑相关障碍暴露疗法的疗效似乎逐渐下降的原因:一项个体参与者数据的荟萃分析。
J Anxiety Disord. 2019 Dec;68:102149. doi: 10.1016/j.janxdis.2019.102149. Epub 2019 Sep 23.
6
Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.D-环丝氨酸增强强迫症认知行为疗法的关键参数。
Am J Psychiatry. 2008 Mar;165(3):293-6. doi: 10.1176/appi.ajp.2007.07121871.
7
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.D-环丝氨酸增强暴露为基础的认知行为疗法治疗焦虑、强迫症和创伤后应激障碍:一项个体参与者数据的系统评价和荟萃分析。
JAMA Psychiatry. 2017 May 1;74(5):501-510. doi: 10.1001/jamapsychiatry.2016.3955.
8
Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.尽管消退持续时间相同,D-环丝氨酸对恐惧的相反作用:脑区与行为之间的相互作用
Neurobiol Learn Mem. 2014 Sep;113:25-34. doi: 10.1016/j.nlm.2013.12.009. Epub 2013 Dec 27.
9
D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.D-环丝氨酸作为焦虑障碍认知行为治疗的增效策略:最新研究进展。
Curr Pharm Des. 2012;18(35):5659-62. doi: 10.2174/138161212803530916.
10
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.D-环丝氨酸与恐惧消退及暴露疗法促进作用的荟萃分析。
Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

引用本文的文献

1
The subjective experience of emotion: a fearful view.情感的主观体验:一种可怕的观点。
Curr Opin Behav Sci. 2018 Feb;19:67-72. doi: 10.1016/j.cobeha.2017.09.011. Epub 2017 Nov 16.
2
Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.近期抗结核药物的生物化学进展:挑战与未来。
Curr Top Med Chem. 2024;24(21):1829-1855. doi: 10.2174/0115680266286294240610102911.
3
Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.协同致幻 - NMDA 受体调节剂治疗神经精神疾病。
Mol Psychiatry. 2024 Jan;29(1):146-152. doi: 10.1038/s41380-023-02312-8. Epub 2023 Nov 9.
4
From childhood adversity to latent stress vulnerability in adulthood: the mediating roles of sleep disturbances and HPA axis dysfunction.从儿童逆境到成年潜在压力脆弱性:睡眠障碍和 HPA 轴功能障碍的中介作用。
Neuropsychopharmacology. 2023 Sep;48(10):1425-1435. doi: 10.1038/s41386-023-01638-9. Epub 2023 Jun 30.
5
The effect of d-cycloserine on brain processing of breathlessness over pulmonary rehabilitation: an experimental medicine study.D-环丝氨酸对肺康复过程中呼吸困难的脑加工的影响:一项实验医学研究。
ERJ Open Res. 2023 Apr 3;9(2). doi: 10.1183/23120541.00479-2022. eCollection 2023 Mar.
6
Anxiety as a disorder of uncertainty: implications for understanding maladaptive anxiety, anxious avoidance, and exposure therapy.焦虑作为一种不确定性障碍:对理解适应不良性焦虑、焦虑回避和暴露疗法的启示。
Cogn Affect Behav Neurosci. 2023 Jun;23(3):844-868. doi: 10.3758/s13415-023-01080-w. Epub 2023 Mar 3.
7
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers.在恒河猴中建立酒精使用障碍的线索暴露治疗模型:潜在认知增强剂的影响。
Drug Alcohol Depend. 2023 Feb 1;243:109735. doi: 10.1016/j.drugalcdep.2022.109735. Epub 2022 Dec 10.
8
L-DOPA modulates activity in the vmPFC, nucleus accumbens, and VTA during threat extinction learning in humans.L-DOPA 调节人类在威胁消退学习过程中 vmPFC、伏隔核和 VTA 的活动。
Elife. 2021 Sep 2;10:e65280. doi: 10.7554/eLife.65280.
9
From Research to Practice: Toward the Examination of Combined Interventions for Autism Spectrum Disorders.从研究到实践:迈向对自闭症谱系障碍综合干预措施的检验
Brain Sci. 2021 Aug 16;11(8):1073. doi: 10.3390/brainsci11081073.
10
Experimental Drugs for Panic Disorder: An Updated Systematic Review.用于惊恐障碍的实验性药物:一项更新的系统评价
J Exp Pharmacol. 2021 Apr 15;13:441-459. doi: 10.2147/JEP.S261403. eCollection 2021.

本文引用的文献

1
D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.D-环丝氨酸增强社交焦虑障碍认知行为团体治疗:预后及处方变量
J Consult Clin Psychol. 2013 Dec;81(6):1100-12. doi: 10.1037/a0034120. Epub 2013 Aug 12.
2
D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.D-环丝氨酸增强社交焦虑障碍暴露疗法的效果取决于暴露疗程的成功与否。
J Psychiatr Res. 2013 Oct;47(10):1455-61. doi: 10.1016/j.jpsychires.2013.06.020. Epub 2013 Jul 16.
3
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.D-环丝氨酸作为焦虑症认知行为疗法的一种增效策略。
Biol Mood Anxiety Disord. 2013 Jun 15;3(1):11. doi: 10.1186/2045-5380-3-11.
4
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.D-环丝氨酸作为一种增效策略,与认知行为疗法联合治疗社交焦虑障碍。
Am J Psychiatry. 2013 Jul;170(7):751-8. doi: 10.1176/appi.ajp.2013.12070974.
5
D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.D-环丝氨酸增强恐惧消退具有暴露治疗成功的特异性:高度恐惧症治疗的证据。
Biol Psychiatry. 2013 Jun 1;73(11):1054-8. doi: 10.1016/j.biopsych.2012.12.009. Epub 2013 Jan 16.
6
Augmentation of exposure therapy with post-session administration of D-cycloserine.暴露疗法联合治疗后给予 D-环丝氨酸增强治疗。
J Psychiatr Res. 2013 Feb;47(2):168-74. doi: 10.1016/j.jpsychires.2012.09.024. Epub 2012 Oct 23.
7
A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.一项随机安慰剂对照试验研究 D-环丝氨酸和暴露疗法治疗创伤后应激障碍。
J Psychiatr Res. 2012 Sep;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. Epub 2012 Jun 12.
8
D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.D-环丝氨酸作为焦虑障碍认知行为治疗的增效策略:最新研究进展。
Curr Pharm Des. 2012;18(35):5659-62. doi: 10.2174/138161212803530916.
9
Enhancing exposure-based therapy from a translational research perspective.从转化研究视角强化基于暴露的疗法。
Behav Res Ther. 2007 Sep;45(9):1987-2001. doi: 10.1016/j.brat.2007.06.006. Epub 2007 Jun 17.
10
Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.动物和人类恐惧习得与消退过程中的认知过程:对焦虑症暴露疗法的启示
Clin Psychol Rev. 2008 Feb;28(2):199-210. doi: 10.1016/j.cpr.2007.04.009. Epub 2007 May 3.